Demant A/S

CPSE:DEMANT Stock Report

Market Cap: kr.70.7b

Demant Valuation

Is DEMANT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DEMANT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DEMANT (DKK324.8) is trading below our estimate of fair value (DKK660.72)

Significantly Below Fair Value: DEMANT is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DEMANT?

Other financial metrics that can be useful for relative valuation.

DEMANT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.7x
Enterprise Value/EBITDA17.8x
PEG Ratio2.2x

Price to Earnings Ratio vs Peers

How does DEMANT's PE Ratio compare to its peers?

The above table shows the PE ratio for DEMANT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average59.7x
AMBU B Ambu
130.5x29.5%kr.31.1b
EMBLA Embla Medical hf
31.9x17.4%kr.12.6b
COLO B Coloplast
39.7x12.3%kr.193.3b
6869 Sysmex
36.8x13.3%JP¥1.7t
DEMANT Demant
27.7x12.6%kr.70.7b

Price-To-Earnings vs Peers: DEMANT is good value based on its Price-To-Earnings Ratio (27.7x) compared to the peer average (59.7x).

Price to Earnings Ratio vs Industry

How does DEMANT's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.3%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a18.3%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: DEMANT is good value based on its Price-To-Earnings Ratio (27.7x) compared to the European Medical Equipment industry average (31.6x).

Price to Earnings Ratio vs Fair Ratio

What is DEMANT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DEMANT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.7x
Fair PE Ratio33.3x

Price-To-Earnings vs Fair Ratio: DEMANT is good value based on its Price-To-Earnings Ratio (27.7x) compared to the estimated Fair Price-To-Earnings Ratio (33.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DEMANT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentkr.324.80
kr.334.75
+3.1%
15.5%kr.400.00kr.240.00n/a16
Apr ’25kr.343.00
kr.339.47
-1.0%
15.8%kr.405.00kr.240.00n/a17
Mar ’25kr.353.30
kr.336.53
-4.7%
15.1%kr.400.00kr.240.00n/a17
Feb ’25kr.317.60
kr.298.71
-5.9%
13.5%kr.355.00kr.235.00n/a17
Jan ’25kr.296.00
kr.288.71
-2.5%
15.1%kr.350.00kr.185.00n/a17
Dec ’24kr.282.30
kr.286.76
+1.6%
13.4%kr.335.00kr.185.00n/a17
Nov ’24kr.272.10
kr.287.69
+5.7%
15.4%kr.340.00kr.185.00n/a16
Oct ’24kr.292.60
kr.286.47
-2.1%
15.8%kr.340.00kr.185.00n/a15
Sep ’24kr.285.20
kr.285.94
+0.3%
15.4%kr.340.00kr.185.00n/a16
Aug ’24kr.265.70
kr.264.27
-0.5%
19.1%kr.330.00kr.180.00n/a15
Jul ’24kr.288.50
kr.256.60
-11.1%
20.2%kr.330.00kr.180.00n/a15
Jun ’24kr.269.50
kr.252.13
-6.4%
20.9%kr.330.00kr.180.00n/a15
May ’24kr.292.40
kr.230.79
-21.1%
19.4%kr.330.00kr.180.00kr.321.0014
Apr ’24kr.240.20
kr.222.00
-7.6%
13.2%kr.275.00kr.180.00kr.343.0013
Mar ’24kr.210.00
kr.218.00
+3.8%
14.8%kr.275.00kr.180.00kr.353.3014
Feb ’24kr.198.10
kr.206.50
+4.2%
13.7%kr.254.00kr.170.00kr.317.6014
Jan ’24kr.192.55
kr.215.23
+11.8%
16.7%kr.285.00kr.165.00kr.296.0013
Dec ’23kr.206.20
kr.215.25
+4.4%
17.2%kr.285.00kr.165.00kr.282.3012
Nov ’23kr.208.30
kr.249.08
+19.6%
19.9%kr.330.00kr.176.00kr.272.1012
Oct ’23kr.188.95
kr.270.36
+43.1%
13.2%kr.330.00kr.200.00kr.292.6011
Sep ’23kr.221.80
kr.278.09
+25.4%
10.0%kr.330.00kr.232.00kr.285.2011
Aug ’23kr.279.20
kr.308.09
+10.3%
12.3%kr.375.00kr.232.00kr.265.7011
Jul ’23kr.272.10
kr.317.45
+16.7%
14.7%kr.390.00kr.232.00kr.288.5011
Jun ’23kr.302.60
kr.308.46
+1.9%
16.6%kr.390.00kr.225.00kr.269.5013
May ’23kr.312.90
kr.304.64
-2.6%
16.7%kr.390.00kr.225.00kr.292.4014

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.